Internationally renowned chemical biologist Dr. Carolyn Bertozzi, whose research is applied worldwide in the biopharmaceutical industry, has achieved extraordinary success for her pioneering inventions in the field of biotechnology. The proven potential for future advances, and her current work manipulating processes within living cells to engineer their surfaces and secreted proteins, have won Bertozzi the prestigious 2010 $500,000 Lemelson-MIT Prize. She will accept the prize and present her accomplishments to the public at the Massachusetts Institute of Technology during the Lemelson-MIT Program’s fourth-annual EurekaFest, a multi-day celebration of the inventive spirit, June 16-19.
Bertozzi’s ability to identify unmet needs and craft innovative solutions has led to scientific advances with a broad range of applications. Chemical insights gleaned by Bertozzi have progressed efforts to diagnose and treat diseases such as cancer, inflammatory disorders such as arthritis, and infectious diseases like tuberculosis. Her multi-disciplinary approach has led to significant developments in the ability to engineer living cells and the proteins they produce with defined chemical properties. As a University of California, Berkeley Professor and Director of the Molecular Foundry at the Lawrence Berkeley National Laboratory, Bertozzi and her team study the biology of glycans, also known as complex carbohydrates, and develop nanotechnologies for probing biological systems.
To read the full press release about this year's winner, please visit http://web.mit.edu/invent/n-pressreleases/n-press-10LMP.html.
The Lemelson-MIT Program recognizes the outstanding inventors and innovators transforming our world, and inspires young people to pursue creative lives and careers through innovation.